MBD2 and neoplasm: Low expression of METTL14 is also greatly associated with clinicopathological characteristics such as TNM stage, differentiation, tumor encapsulation, tumor microsatellite, and microvascular invasion.169,170,185,240 FTO and ALKBH5 are demethylases that maintain the dynamic balance of m6A modification.